Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,148
Total Claims
$3.7M
Drug Cost
155
Beneficiaries
$24K
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+56%
Opioid rate vs peers
9.8% vs 6.3% avg
+77%
Cost per patient vs peers
$24K vs $14K avg
Opioid Prescribing
9.8%
Opioid Rate
112
Opioid Claims
$2,128
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 0 claims · $0
Generic: 733 claims · $26K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Acalabrutinib Maleate | 102 | $1.3M |
| Ibrutinib | 52 | $674K |
| Zanubrutinib | 32 | $381K |
| Venetoclax | 60 | $373K |
| Pirtobrutinib | 12 | $264K |
| Immun Glob G(Igg)/Gly/Iga 0-50 | 53 | $218K |
| Duvelisib | 15 | $214K |
| Lenalidomide | 11 | $182K |
| Immun Glob G(Igg)/Gly/Iga Ov50 | 24 | $54K |
| Acyclovir | 139 | $1,611 |
| Ondansetron Hcl | 26 | $1,250 |
| Hydrocodone/Acetaminophen | 44 | $1,031 |
| Gabapentin | 30 | $643 |
| Tramadol Hcl | 16 | $346 |
| Oxycodone Hcl | 36 | $313 |
Prescribing Profile
Patient Profile
72
Avg Age
44%
Female
2.24
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About